share_log

图解亚虹医药一季报:第一季度单季净利润同比减31.64%

Stock Star ·  Apr 30 02:14

证券之星消息,亚虹医药2024年一季报显示,公司主营收入2431.95万元,同比上升106217.71%;归母净利润-8284.82万元,同比下降31.64%;扣非净利润-9322.58万元,同比下降25.86%;负债率10.08%,投资收益795.12万元,财务费用-1075.19万元,毛利率78.97%。

财报数据概要请见下图:


图片

以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment